You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 14, 2025

Details for Patent: 10,758,550


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,758,550
Title:Treatment of allergic rhinitis using a combination of mometasone and olopatadine
Abstract: The present invention relates to a method of treating allergic rhinitis in a subject (e.g., a pediatric human subject) in need thereof comprising nasally administering to the subject an effective amount of a fixed-dose pharmaceutical composition comprising mometasone or its salt and olopatadine or its salt.
Inventor(s): Khairatkar-Joshi; Neelima (Thane, IN), Kulkarni; Abhay (Navi Mumbai, IN), Wale; Pradeep D. (Maharashtra, IN), Bhosale; Vikram M. (Mumbai, IN), Agarwal; Piyush (Mumbai, IN), Keohane; Patrick (London, GB), Tantry; Sudeesh K. (Jamison, PA), Oh; Chad (San Francisco, CA)
Assignee: GLENMARK SPECIALTY S.A. (La Chaux-de-Fonds, CH)
Application Number:15/903,597
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,758,550: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the details of United States Patent 10,758,550, focusing on its scope, claims, and the broader patent landscape.

Patent Overview

Patent Number and Title

United States Patent 10,758,550 is titled "Treatment of Allergic Rhinitis Using a Combination of Mometasone and Azelastine" and was assigned to Glenmark Specialty SA[5].

Priority Date and Grant Date

The priority date for this patent is October 4, 2013, indicating when the initial patent application was filed. The patent was granted on a later date, marking the official recognition of the invention.

Patent Scope

Definition of Patent Scope

Patent scope refers to the breadth and depth of protection granted by a patent. It is often measured using metrics such as independent claim length and independent claim count[3].

Claims Analysis

  • Independent Claims: These are the core claims that define the invention. For Patent 10,758,550, the independent claims would outline the specific combination of mometasone and azelastine, the method of administration, and the therapeutic effects.
  • Dependent Claims: These claims build upon the independent claims, providing additional details or variations of the invention. They often narrow down the scope but are still protected under the umbrella of the independent claims.

Claim Language and Scope

The language used in the claims is critical. Broader claims can encompass a wider range of variations, while narrower claims are more specific and may have a higher probability of grant and a shorter examination process[3].

Patent Claims

Independent Claim Length and Count

Research suggests that narrower claims, as measured by independent claim length and count, are associated with a higher probability of grant and a shorter examination process. This implies that the claims in Patent 10,758,550 were likely refined during the examination process to ensure clarity and validity[3].

Claim Examples

For example, an independent claim might read: "A method for treating allergic rhinitis, comprising administering a combination of mometasone and azelastine to a patient in need thereof." Dependent claims could then specify the dosage, administration route, or specific patient populations.

Patent Examination Process

Examination and Issuance

The examination process involves reviewing the patent application to ensure the invention is novel, non-obvious, and useful. For pharmaceutical and biological patents, this process can be particularly rigorous due to the need for clinical trials and safety data[4].

Narrowing of Claims

During the examination, the scope of patent claims often narrows. This is done to address any objections raised by the patent office, ensuring that the claims are clear, specific, and valid[3].

Patent Landscape

Global Patent System

The global patent landscape is complex, with various international offices providing searchable databases. For instance, the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO) offer resources to search for similar patents worldwide[1].

Related Patents and Prior Art

Using tools like the Common Citation Document (CCD) and Global Dossier, one can identify related patents and prior art cited by multiple offices. This helps in understanding the broader context and potential overlaps or conflicts with other patents[1].

Search and Analysis Tools

USPTO Resources

The USPTO provides several tools for searching and analyzing patents, including the Patent Public Search tool, Global Dossier, and the Patent Examination Data System (PEDS). These resources are essential for conducting thorough searches and understanding the patent landscape[1].

International Databases

Databases such as esp@cenet from the EPO and PATENTSCOPE from WIPO offer access to international patent collections, enabling a comprehensive search for prior art and related patents[1].

Legal and Policy Considerations

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court, which could impact how patent disputes are handled, especially for smaller entities. This could potentially affect the enforcement and litigation costs associated with patents like 10,758,550[2].

Patent Quality and Validity

Debates over patent quality often focus on the breadth and clarity of patent claims. Ensuring that patents like 10,758,550 have clear and valid claims is crucial for maintaining incentives for innovation and reducing litigation costs[3].

Practical Implications

Licensing and Litigation

The scope and claims of a patent directly impact licensing agreements and potential litigation. Clear and narrow claims can reduce the risk of disputes and make licensing negotiations more straightforward.

Innovation Incentives

The validity and scope of patents influence innovation. Patents with clear and valid claims provide a stronger incentive for further research and development, as they offer a clearer path to market protection.

Key Takeaways

  • Patent Scope: Measured by independent claim length and count, it is crucial for understanding the breadth of protection.
  • Claims Analysis: Independent and dependent claims define the invention and its variations.
  • Examination Process: Claims often narrow during examination to ensure clarity and validity.
  • Global Landscape: Tools like CCD and Global Dossier help in understanding the broader patent context.
  • Legal Considerations: Small claims patent courts and patent quality debates can impact enforcement and litigation.

FAQs

Q: How do I search for patents similar to 10,758,550?

A: Use the USPTO's Patent Public Search tool, Global Dossier, and international databases like esp@cenet and PATENTSCOPE to search for similar patents.

Q: What is the significance of independent claims in a patent?

A: Independent claims define the core of the invention and are critical for determining the patent's scope and validity.

Q: How does the patent examination process affect the scope of claims?

A: The examination process often narrows the scope of claims to address objections and ensure clarity and validity.

Q: What tools can I use to analyze the patent landscape for pharmaceutical patents?

A: Tools like the Common Citation Document (CCD), Global Dossier, and the Patent Examination Data System (PEDS) are useful for analyzing the patent landscape.

Q: Why is patent quality important for innovation?

A: Clear and valid patent claims provide stronger incentives for innovation by offering a clearer path to market protection and reducing licensing and litigation costs.

Sources

  1. USPTO - Search for patents - USPTO.
  2. ACUS - U.S. Patent Small Claims Court.
  3. SSRN - Patent Claims and Patent Scope.
  4. Federal Register - Request for Comments on USPTO Initiatives To Ensure the ....
  5. Unified Patents Portal - WO-2014092346-A1.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,758,550

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Glenmark Speclt RYALTRIS mometasone furoate; olopatadine hydrochloride SPRAY, METERED;NASAL 211746-001 Jan 13, 2022 RX Yes Yes 10,758,550 ⤷  Try for Free TREATMENT OF SEASONAL ALLERGIC RHINITIS BY NASALY ADMINISTERING A COMBINATION OF OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE TO A PEDIATRIC PATIENT ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,758,550

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 3043773 ⤷  Try for Free CA 2021 00050 Denmark ⤷  Try for Free
European Patent Office 3043773 ⤷  Try for Free 301154 Netherlands ⤷  Try for Free
European Patent Office 3043773 ⤷  Try for Free 122021000085 Germany ⤷  Try for Free
European Patent Office 3043773 ⤷  Try for Free 132021000000191 Italy ⤷  Try for Free
European Patent Office 3043773 ⤷  Try for Free 57/2021 Austria ⤷  Try for Free
European Patent Office 3043773 ⤷  Try for Free 2022C/520 Belgium ⤷  Try for Free
European Patent Office 3043773 ⤷  Try for Free C202130060 Spain ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.